医学
肝再生
肝移植
肝切除术
移植
内科学
甲基强的松龙
内分泌学
再生(生物学)
胃肠病学
外科
生物
切除术
细胞生物学
作者
Yoshinobu Sato,Hidenori Watanabe,Hitoshi Kameyama,Takashi Kobayashi,Shinji Yamamoto,Toshiyuki Takeishi,Keisuke Hirano,Hiroshi Oya,Hideki Nakatsuka,Toshiaki Watanabe,H. Kokai,Satoshi Yamagoe,Kazuo Suzuki,Kiyofumi Oya,Kensuke Kojima,K. Hatakeyama
标识
DOI:10.1016/j.transproceed.2004.07.006
摘要
We investigated changes in serum leukocyte cell-derived chemotaxin2 (LECT2) levels between donors and recipients in the early period during liver regeneration following adult living related donor liver transplantation (LRDLT). Five recipients (three women, two men; 37.0 ± 15.8 years old), all of whom had end-stage liver failure, underwent LRDLT from healthy five donors (two women, three men; 41.6 ± 14.3 years old) between June 2000 and February 2001. FK506 and methylprednisolone were used as immunosuppressants for recipients. Serum LECT2 levels decreased immediately after both the hepatectomy in all donors and the implantation of liver graft in all recipients. Donors showed a nadir at 3 to 12 hours, increasing at 24 to 48 hours. The nadir in recipients occurred several hours after the donors. The serum LECT2 levels of donors were significantly higher than those of recipients on day 5 (9.5 ± 5.9 ng/mL vs 3.1 ± 2.2 ng/mL, P = .04) and on day 7 (9.3 ± 3.8 ng/mL vs 3.5 ± 1.1 ng/mL, P = .04). Serum GPT and GOT levels were inversely proportionate to the serum LECT2 levels. The present studies suggest that LECT2 participates in liver regeneration and injury following hepatectomy.
科研通智能强力驱动
Strongly Powered by AbleSci AI